Microbot Medical
MBOT
26 hedge funds and large institutions have $5.28M invested in Microbot Medical in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
4% more funds holding
Funds holding: 25 → 26 (+1)
0.1% less ownership
Funds ownership: 10.88% → 10.78% (-0.1%)
11% less capital invested
Capital invested by funds: $5.93M → $5.28M (-$654K)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
| 2 |
Renaissance Technologies
New York
|
+$122K |
| 3 |
BlackRock
New York
|
+$11.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$6.6K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$268K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$45K |
| 3 |
XI
XXEC Inc
Tulsa,
Oklahoma
|
-$23.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
MBOT Hedge Fund Activity: Q4 2020 in Review
26 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2020, worth a combined $5.28M — down 11% from $5.93M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new MBOT positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $170K. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $268K.
- 26 institutional investors held Microbot Medical (MBOT) as of Q4 2020, up from 25 in Q3 2020.
- Funds reported $5.28M of Microbot Medical stock for Q4 2020, down 11% quarter-over-quarter.
- 3 funds opened new Microbot Medical positions in Q4 2020 and 2 closed out, a net change of +1 holder.
- The largest Microbot Medical buyer in Q4 2020 was Vanguard Group, an estimated $170K added.
- The largest Microbot Medical seller in Q4 2020 was Qube Research & Technologies (QRT), an estimated $268K sold.
Based on aggregated 13F filings for Q4 2020.